· Журналы · Книги · О проекте ·Электронные версии книг издательства “Атмосфера” поступили в продажу Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru ИНТЕРНЕТ-МАГАЗИН    Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print) 2020 / N 1 Внебольничная пневмония у лиц с сахарным диабетом: эпидемиология, этиология, диагностика, лечение и профилактика Р.Э.-П. Байсултанова, С.А. Рачина, М.В. Сухорукова, Н.В. Иванчик References 1.Global Burden of Disease. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 2012 Dec;380(9859):2095-128. 2.Wroe PC, Finkelstein JA, Ray GT, Linder JA, Johnson KM, Rifas-Shiman S, Moore MR, Huang SS. Aging population and future burden of pneumococcal pneumonia in the United States. Journal of Infectious Diseases 2012;205:1589-92. 3.Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012 Jan;67(1):71-9. 4.Federal Service on Surveillance of Consumer Rights Protection and Human Wellbeing. Statistical data. Infectious diseases in the Russian Federation for Jan-Dec 2018. Moscow, 2018 (In Russian). 5.Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN, Fine MJ. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Archives in Internal Medicine 2002 May;162(9):1059-64. 6.Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996 Jan;275(2):134-41. 7.Søgaard M, Nielsen RB, Schønheyder HC, Nørgaard M, Thomsen RW. Nationwide trends in pneumonia hospitalization rates and mortality, Denmark 1997–2011. Respiratory Medicine 2014 Aug;108(8):1214-22. 8.World Health Organization. The top 10 causes of death: 2018 update. Available from: http://www.who.int Accessed 2020 Aug 10. 9.Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Annals of Internal Medicine 2003 Jan;138(2):109-18. 10.Mandell LM, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clinical Infectious Diseases 2007 Mar:44(Suppl 2):S27-72. 11.Global report on diabetes. Geneva: WHO; 2018. License: CC BY-NC-SA 3.0. IGO. (In Russian). 12.International Diabetes Federation. IDF diabetes atlas. 7th ed. Brussels: IDF; 2015. 144 p. 13.Shestakova MV, Vikulova OK, Zheleznyakova AV, Isakov MA, Dedov II. Epidemiology of diabetes in the Russian Federation: what has changed over the past decade? Therapeutic Archive 2019;91(10):4-13 (In Russian). 14.Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infections disease hospitalization and outcome. Diabetologia 2007 Mar;50(3):549-54. 15.Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, Sørensen HT. Diabetes, glycaemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care 2008 Aug;31(8):1541-5. 16.Bruns AH, Oosterheert JJ, Cucciolillo MC, Moussaoui REI, Groenwold RHH, Prins JM, Hoepelman AIM. Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population. Clinical Microbiology and Infection 2011 May;17(5):763-8. 17.Mortensen EM, Kapoor WN, Chang CC, Fine MJ. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clinical Infectious Diseases 2003 Dec;37(12):1617-24. 18.Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003 Feb;26(2):510-3. 19.Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schønheyder HC, Sørensen HT. Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clinical Infectious Diseases 2005 Feb;40(4):628-31. 20.Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Sørensen HT, Schønheyder HC. Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study. Diabetes Care 2004 Jan;27(1):70-6. 21.Burekovic A, Dizdarevic-Bostandzic A, Godinjak A. Poorly regulated blood glucose in diabetic patients – predictor of acute infections. Medical Archives (Sarajevo, Bosnia and Herzegovina) 2014 Jun;68(3):163-6. 22.Jensen AV, Faurholt-Jepsen D, Egelund GB, Andersen SB, Petersen PT, Benfield T, Witzenrath M, Rohde G, Ravn P; German Community-Acquired Pneumonia Competence Network (CAPNETZ). Undiagnosed diabetes mellitus in community-acquired pneumonia: a prospective cohort study. Clinical Infectious Diseases 2017 Nov;65(12):2091-8. 23.Lepper PM, Ott S, Nüesch E, Maximilian von Eynatten, Schumann C, Pletz MW, Mealing NM, Welte T, Bauer TT, Suttorp N, Jüni P, Bals R, Rohde G; German Community Acquired Pneumonia Competence Network. Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. BMJ 2012 May;344:e3397. 24.Kasper DL, Harrison TR. Harrison’s principles of internal medicine. 16th ed. New York: McGraw-Hill; 2005: 2152-3. 25.Cheepsattayakorn A, Cheepsattayakorn R. Pulmonary infectious diseases in association with diabetes mellitus. Journal of Lung, Pulmonary & Respiratory Research 2017;4(3):00127. 26.Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, Sørensen HT. Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care 2007 Sep;30(9):2251-7. 27.Li S, Wang J, Zhang B, Li X, Liu Y. Diabetes mellitus and cause-specific mortality: a population-based study. Diabetes & Metabolism Journal 2019 Jun;43(3):319-41. 28.Valerius NH, Eff C, Hansen NE, Karle H, Nerup J, Søeberg B, Sørensen SF. Neutrophil and lymphocyte function in patients with diabetes mellitus. Acta Medica Scandinavica 1982;211(6):463-7. 29.Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992 Feb;15(2):256-60. 30.Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabetic Medicine 1997 Jan;14(1):29-34. 31.Koziel H, Koziel MJ. Pulmonary complications of diabetes mellitus. Pneumonia. Infectious Disease Clinics of North America 1995 Mar;9(1):65-90. 32.Ljubić S, Balachandran A, Pavliæ-Renar I, Metelko Ž. Pulmonary infections in diabetes mellitus. Diabetologia Croatica 2005 Mar:33(4):115-24. 33.Ngo BT, Hayes KD, Dimiao DJ, Srinivasan SK, Huerter CJ, Rendell MS. Manifestations of cutaneous diabetic microangiopathy. American Journal of Clinical Dermatology 2005;6(4):225-37. 34.Ljubić S, Metelko Ž, Car N, Roglić G, Drazić Z. Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest 1998 Oct;114(4):1033-5. 35.Johanson WGJ, Woods DE, Chaudhuri T. Association of respiratory tract colonization with adherence of gram-negative bacilli to epithelial cells. The Journal of Infectious Diseases 1979 Jun;139(6):667-73. 36.Gross AE, Van Schooneveld TC, Olsen KM, Rupp ME, Bui TH, Forsung E, Kalil AC. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia. Antimicrobial Agents and Chemotherapy 2014 Sep;58(9):5262-8. 37.Torres A, Blasi F, Peetermans WE, Viegi G, Welte T. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. European Journal of Clinical Microbiology & Infectious Diseases 2014 Jul;33(7):1065-79. 38.Zakharenkov IA, Rachina SA, Dekhnich NN, Kozlov RS, Sinopalnikov AI, Ivanchik NV, Yatsyshina SB, Yeltsina MA, Archipenko MV, Gordeyeva SA, Lebedeva MS, Portnyagina US. Etiology of severe community-acquired pneumonia in adults: results of the first Russian multicenter study. Therapeutic Archive 2020;92(1):36-42 (In Russian). 39.Bjarnason A, Westin J, Lindh M, Andersson LM, Kristinsson KG, Löve A, Baldursson O, Gottfredsson M. Incidence, etiology, and outcomes of community-acquired pneumonia: a population-based study. Open Forum Infectious Diseases 2018 Feb;5(2):ofy010. 40.Choi SH, Hong SB, Ko GB, Lee Y, Park HJ, Park SY, Moon SM, Cho OH, Park KH, Chong YP, Kim SH, Huh JW, Sung H, Do KH, Lee SO, Kim MN, Jeong JY, Lim CM, Kim YS, Woo JH, Koh Y. Viral infection in patients with severe pneumonia requiring intensive care unit admission. American Journal of Respiratory and Critical Care Medicine 2012 Aug;186(4):325-32. 41.Niyas VKM, Kumar S. Community acquired pneumonia in type 2 diabetes mellitus: a study of clinical and bacteriological profile. Journal of Evidence Based Medicine and Healthcare 2016 Jan;3(17):656-61. 42.Lipsky BA, Pecoraro RE, Chen MS, Koepsell TD. Factors affecting staphylococcal colonization among NIDDM outpatients. Diabetes Care 1987 Jul-Aug;10(4):483-6. 43.Boyko EJ, Lipsky BA, Sandoval R, Keane EM, Monahan JS, Pecoraro RE, Hamman FR. NIDDM and prevalence of nasal Staphylococus aureus colonization. San Luis Valley Diabetes Study. Diabetes Care 1989 Mar;12(3):189-93. 44.Iwahara T, Ichiyama S, Nada T, Shimokata K, Nakashima N. Clinical and epidemiological investigations of nosocomial pulmonary infections caused by methicillin-resistant Staphylococcus aureus. Chest 1994 Mar;105(3):826-31. 45.Liu YN, Chen MJ, Zhao TM, Wang H, Wang R, Liu QF, Cai BQ, Cao B, Sun TY, Hu YJ, Xiu QY, Zhou X, Ding X, Yang L, Zhuo JS, Tang YC, Zhang KX, Liang DR, Lü XY, Li SQ, Liu Y, Yu YS, Wei ZQ, Ying KJ, Zhao F, Chen P, Hou XN. A multicentre study on the pathogenic in 665 adult patients with community-acquired pneumonia in cities of China. Zhonghua Jie He He Hu Xi Za Zhi 2006 Jan;29(1):3-8. 46.Levinson M, Kaye D. Pneumonia caused by gram-negative bacilli; an overview. Reviews of Infectious Diseases 1985 Nov-Dec;7(Suppl 4):S656-65. 47.Bartlett JG, Gorbach SL. The triple threat of aspiration pneumonia. Chest 1975 Oct;68(4):560-6. 48.Horwitz MA. Cell-mediated immunity in Legionnaires’ disease. The Journal of Clinical Investigation 1983 Jun;71(6):1686-97. 49.Pachon J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A. Severe community-acquired pneumonia: etiology, prognosis, and treatment. The American Reviews of Respiratory Disease 1990 Aug;142(2):369-73. 50.England AC 3rd, Fraser DW. Sporadic and epidemic nosocomial legionellosis in the United States. Epidemiological features. The American Journal of Medicine 1981 Mar;70(3):707-11. 51.Rachina SA, Sinopalnikov AI. Clinical guidelines for community-acquired pneumonia in adults: version 2019. Practical Pulmonology 2018;3:8-13 (In Russian). 52.Russian Respiratory Society; Interregional Association on Clinical Microbiology and Antimicrobial Chemotherapy. Clinical guidelines on diagnosis, treatment, and prevention of severe community-acquired pneumonia in adults. Russian Pulmonology 2014;14(4):13-48 (In Russian). 53.Ministry of Healthcare of the Russian Federation. Russian Respiratory Society; Interregional Association on Clinical Microbiology and Antimicrobial Chemotherapy. Clinical guidelines. Community-acquired pneumonia in adults. ICD 10: J13-J18. Year of approval (frequency of revision): 2019 (revised every 3 years). Moscow, 2019. 97 p. (In Russian). 54.Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, Macfarlane JT, Read RC, Roberts HJ, Levy ML, Wani M, Woodhead MA; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. British Thoracic Society guidelines for the management of community-acquired pneumonia in adults: update 2009. Thorax 2009 Oct;64(Suppl 3):iii1-55. 55.Standards of specialized diabetes care. Clinical guidelines. Dedov II, Shestakova MV, Mayorov AYu, editors. 8th issue. Moscow: UP Print; 2017. 112 p. (In Russian). 56.Rachina SA, Ivanchik NV, Kozlov RS. Microbiology diagnostics of community-acquired pneumonia in adults. Practical Pulmonology 2016;4:40-7 (In Russian). 57.Rachina SA, Bobylev AA. Atypical pathogens of community-acquired pneumonia: epidemiology, diagnosis, and treatment. Practical Pulmonology 2016;2:20-7 (In Russian). 58.Wiersinga WJ, Bonten MJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, Schouten JA, Degener JE, van de Garde EMW, Verheij TJ, Sachs APE, Prins JM. Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT). The Netherlands Journal of Medicine 2018 Jan;76(1):1-13. 59.Federal Service on Surveillance of Consumer Rights Protection and Human Wellbeing. MUK 4.2.3115-13. Laboratory diagnostics of community-acquired pneumonia: guidelines. Moscow, 2014. 39 p. (In Russian). 60.Federal Service on Surveillance of Consumer Rights Protection and Human Wellbeing. State sanitary and epidemiological regulation of the Russian Federation. Epidemiological surveillance of community-acquired pneumonia: guidelines. MU 3.1.2.3047-13. Clinical Microbiology and Antimicrobial Chemotherapy 2014;16(2):88-99 (In Russian). 61.Garcia LS, Isenberg HD. Clinical microbiology procedures handbook. 3d ed. Washington, DC: ASM Press; 2010. 2681 p. 62.Interregional Association on Clinical Microbiology and Antimicrobial Chemotherapy. Clinical guidelines. Determination of the sensitivity of microorganisms to antimicrobial drugs. Version 2015-02. Moscow, 2015. 162 p. (In Russian). 63.The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 10.0, 2020. Available from: http://www.eucast.org Accessed 2020 Aug 10. 64.Carreno JJ, Lodise TP. Ceftaroline fosamil for the treatment of community-acquired pneumonia: from FOCUS to CAPTURE. Infectious Diseases and Therapy 2014 Dec;3(2):123-3. 65.Bruns AH, Oosterheert JJ, Hak E, Hoepelman AIM. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. European Respiratory Journal 2008 Sep;32(3):726-32. 66.Nseir W, Farah R, Mograbi J, Machoul N. Impact of serum C-reactive protein measurements in the first 2 days on the 30-day mortality in hospitalized patients with severe community-acquired pneumonia: a cohort study. Journal of Critical Care 2013 Jun;28(3):291-5. 67.Mayorov AYu, Surkova EV, Galstyan GR, Tsibina LV. Current approaches to insulin therapy for type 2 diabetes. Diabetes Mellitus 2003;4:51-7 (In Russian). 68.Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Available from: https://www.cdc.gov/vaccines/schedules/downloads/adult/adult-combined-schedule.pdf Accessed 2020 Aug 10. 69.Kozlov RS, Avdeyev SN, Briko NI, Bilichenko TN, Kostinov MP, Sidorenko SV, Kharit SM, Sinopalnikov AI, Zaytsev AA, Shubin IV, Demko IV, Ignatova GL, Rachina SA, Feldblum IV. Pneumococcal vaccination in adults. Resolution of the Expert Council (Moscow, 2017 Dec 16). Clinical Microbiology and Antimicrobial Chemotherapy 2018;20(1):5-8 (In Russian).    [ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]